← Back to news

Markets

Jim Cramer on Backblaze: “Solid Company, Just Not the Right Time”

Y

Jim Cramer on JPMorgan: “If You Bought It, It’s Not Going to Be Bad”

Y

Jim Cramer on DraftKings: “This Thing Finally Has Momentum”

Y

Jim Cramer on UnitedHealth: “Buy It”

Y

Jim Cramer on TJX: “It’s an Ideal Place to Shop for Value”

Y

Jim Cramer on Simon Property Group: “Terrific Record, Buy It”

Y

Fed Chair Kevin Warsh and the FOMC Will Likely Take the First Step Toward Dropping the Hammer on Trumpflation This Week

Y

Stocks gain, oil slides as Trump says Iran deal signed

Y

Dollar falls to 10-day low on US-Iran war deal

Y

Jim Cramer on Monster Beverage: “Buy It Into the Tsunami, It’ll Work”

Y

Jim Cramer on Coca-Cola: “This Is a Quintessential Defensive Stock”

Y

Jim Cramer Calls KLA Corporation “Too Risky”

Y

Jim Cramer Calls Kimco Realty “Very Defensive”

Y

Jim Cramer Discusses Johnson Controls As Some Data Center Peers Slump

Y

Jim Cramer on Humana: “This Is a Textbook Safety Stock”

Y

Jim Cramer on W.W. Grainger: “I Couldn’t Figure That One Out”

Y

Jim Cramer on Fortive: “It’s Nothing Special, Frankly”

Y

The S&P 500's Missing Giant: What Happens If The 6th-Largest Stock Stays Out A Full Year?

S

Ondas: Defense Moat Vs. 324% Share Dilution

S

Uber: The Delivery Hero Transaction Enhances A Powerful Growth Story

S

Musk says SpaceX could bring $1 trillion in revenue by 2030

Y

Stifel Lowers Donaldson (DCI) Target as Company Tightens Organic Growth Guidance

Y

BMO Capital Cuts Sherwin-Williams (SHW) Price Target on Challenging Macro Outlook

Y

India's Electronics Mart eyes new markets as tech hubs fear job losses

Y

Is CVS Health (CVS) One of Billionaire Larry Robbins’ 10 Dividend Stock Picks?

Y

Global Payments (GPN) – Among Billionaire Larry Robbins’ 10 Dividend Stock Picks

Y

Citi Calls AMD a Rising Force in the GPU Market, Upgrades Shares to Buy

Y

Meta Completes Operational Split from Manus amid Unwinding of $2 Billion Deal, Bloomberg Reports

Y

Applied Materials (AMAT) Gets Higher Price Targets from Barclays and Cantor Fitzgerald

Y

JPMorgan and Mizuho Raise Humana (HUM) Price Targets as Managed Care Outlook Improves

Y

Piper Sandler Begins Coverage of Danaher (DHR) While Waiting for New Growth Catalysts

Y

Citi Sticks with Buy on Baker Hughes (BKR) Despite Lowering Price Target

Y

Meta: Valuation Gap Is Hard To Ignore

S

Piper Sandler Launches Coverage on Bio-Techne (TECH), Prefers Patience on Sector Growth Drivers

Y

Lumentum: A High-Risk, High-Reward AI Infrastructure Play

S

Blue Owl Capital: Once-In-A-Decade Opportunity

S

Morning Bid: Markets celebrate MOU on SoH

Y

Vanguard Dethrones BlackRock as America’s ‘Definitive King’ of ETFs

Y

Behind the TMX Deal to Buy RAFI Indices From Research Affiliates

Y

Why European, Especially German, Automakers are Going on Defense, Literally

Y

Wall Street Is Preparing for Kevin Warsh’s First FOMC Meeting as Head of the Fed

Y

Schwab Follows Vanguard With Fee Cuts on 4 ETFs

Y

Woodside Denies Exxon Deal Talks Amid Takeover Speculation

Y

Stocks leap worldwide, and oil prices drop after the US and Iran reach a tentative deal on their war

Y

Diversification Is Better than a Free

Y

Markets cheer Iran deal, wait for oil to start flowing

Y

Stock market today: Dow hits record, S&P 500, Nasdaq soar as tech rallies amid US-Iran pact to reopen Hormuz

Y

What Does an Adaptive Biotech Insider's Sale of Nearly 40,000 Shares Mean for Investors?

Y

Longtime SpaceX Investor Cathie Wood Made This Move on IPO Day. Should You Follow?

Y

Elon Musk Projects $1 Trillion SpaceX Revenue by 2030: Practical or a Long Shot?

Y